{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:14:00Z","timestamp":1648750440985},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf01738153","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T06:16:10Z","timestamp":1118643370000},"page":"978-987","source":"Crossref","is-referenced-by-count":4,"title":["Medikament\u00f6se Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra"],"prefix":"10.1007","volume":"63","author":[{"given":"K.","family":"Andrassy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Waldherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01738153_CR1","unstructured":"Frerichs T (1851) Die Bright'sche Nierenerkrankung und deren Behandlung. Vieweg Verlag Braunschweig"},{"key":"BF01738153_CR2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/978-1-4612-5284-9_129","volume-title":"Nephrology, Vol II","author":"J Cameron","year":"1984","unstructured":"Cameron J (1984) Treatment of glomerulonephritis based on knowledge of its pathogenesis. In: Robinson R (ed) Nephrology, Vol II. Springer-Verlag, Heidelberg, pp 1445\u20131463"},{"key":"BF01738153_CR3","first-page":"755","volume":"99","author":"J Cameron","year":"1982","unstructured":"Cameron J (1982) Glomerulonephritis: current problems and understanding. J Lab Clin Med 99:755\u2013787","journal-title":"J Lab Clin Med"},{"key":"BF01738153_CR4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1984.225","volume":"26","author":"S Adler","year":"1984","unstructured":"Adler S, Baker P, Pritzl P, Couser P (1984) Detection of terminal complement components in experimental immune glomerular injury. Kidney Int 26:830\u2013837","journal-title":"Kidney Int"},{"key":"BF01738153_CR5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.1985.39","volume":"27","author":"A Rehan","year":"1985","unstructured":"Rehan A, Johnson K, Kunkel R, Wiggins R (1985) Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury. Kidney Int 27:503\u2013511","journal-title":"Kidney Int"},{"key":"BF01738153_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-1-4612-5284-9_55","volume-title":"Nephrology, Vol I","author":"M Dunn","year":"1984","unstructured":"Dunn M, Lianos E, Stork J (1984) Glomerular arachidonic acid metabolism in nephrotoxic serum nephritis. In: Robinson R (ed) Nephrology, Vol I. Springer, Heidelberg, pp 601\u2013608"},{"key":"BF01738153_CR7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1172\/JCI102399","volume":"29","author":"J Luetscher","year":"1950","unstructured":"Luetscher J, Deming A, Harvey G, Lew W, Pool L (1950) Treatment of nephrosis with cortisone. J Clin Invest 29:1576\u20131587","journal-title":"J Clin Invest"},{"key":"BF01738153_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3181\/00379727-74-17803","volume":"74","author":"T Addis","year":"1950","unstructured":"Addis T, Marmorston J, Goodman H, Sellers A, Smith M (1950) Effect of adrenalectomy on spontaneous and induced proteinuria in the rat. Proc Soc Exp Biol Med 74:43\u201346","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF01738153_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1069513","volume":"108","author":"M Rambausek","year":"1983","unstructured":"Rambausek M, Seelig H, Andrassy K, Waldherr R, Kejry I, Lenhard V, Ritz E (1983) Mesangiale IgA-Glomerulonephritis. Neue Aspekte zur Diagnose, Klinik und Prognose. Dtsch Med Wochenschr 108:125\u2013130","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01738153_CR10","first-page":"693","volume":"21","author":"M Rambausek","year":"1984","unstructured":"Rambausek M, Waldherr R, Andrassy K, Ritz E (1984) Hypertension in mesangial IgA glomerulonephritis. Proc EDTA 21:693\u2013696","journal-title":"Proc EDTA"},{"key":"BF01738153_CR11","first-page":"49","volume":"13","author":"G Gallo","year":"1978","unstructured":"Gallo G, Feiner A, Steele M, Schacht R, Gluck M, Baldwin D (1978) Role of intrarenal vascular sclerosis in progression of poststreptococcal glomerulonephritis. Clin Nephrol 13:49\u201357","journal-title":"Clin Nephrol"},{"key":"BF01738153_CR12","volume-title":"Die Niere","author":"A Bohle","year":"1984","unstructured":"Bohle A, G\u00e4rtner HV, Haberke HG, Kr\u00fcck F (1984) Die Niere. Schattauer, Stuttgart"},{"key":"BF01738153_CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-2008-1069604","volume":"108","author":"E Ritz","year":"1983","unstructured":"Ritz E, Mauerhoff T, Andrassy K, Kreusser W (1983) Lupus Nephritis. Wann, wie und womit soll behandelt werden? Dtsch Med Wochenschr 108:591\u2013594","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01738153_CR14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"H Austin","year":"1984","unstructured":"Austin H, Muenz L, Joyce K, Antonovych T, Balow J (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Intern 25:689\u2013695","journal-title":"Kidney Intern"},{"key":"BF01738153_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-91-4-587","volume":"91","author":"J Decker","year":"1979","unstructured":"Decker J, Steinberg A, Reinertson J, Plotz P, Balow J, Klippel J (1979) Systemic lupus erythematosus: evolving concepts. Ann Int Med 91:587\u2013604","journal-title":"Ann Int Med"},{"key":"BF01738153_CR16","doi-asserted-by":"crossref","unstructured":"Collaborative study of the adult idiopathic nephrotic syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy (1979) New Engl J Med 301:1301\u20131306","DOI":"10.1056\/NEJM197912133012401"},{"key":"BF01738153_CR17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9343(79)90486-8","volume":"66","author":"L Noel","year":"1979","unstructured":"Noel L, Zanetti M, Droz D, Barbanel C (1979) Long-term prognosis of idiopathic membranous glomerulonephritis. Am J Med 66:82\u201390","journal-title":"Am J Med"},{"key":"BF01738153_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000407068","volume":"33","author":"J Donadio","year":"1982","unstructured":"Donadio J (1982) Primary glomerular disease: to treat or not to treat. Contr Nephrol 33:86\u2013103, Karger, Basel","journal-title":"Contr Nephrol"},{"key":"BF01738153_CR19","first-page":"672","volume":"58","author":"H Sarre","year":"1963","unstructured":"Sarre H (1963) Kortikosteroidtherapie beim nephrotischen Syndrom. Med Klin 58:672\u2013676","journal-title":"Med Klin"},{"key":"BF01738153_CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","volume":"3","author":"D Black","year":"1970","unstructured":"Black D, Rose G, Brewer D (1970) Controlled trial of prednisone in adult patients with the nephrotic syndrome. Brit Med J 3:421\u2013426","journal-title":"Brit Med J"},{"key":"BF01738153_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.2.5756.239","volume":"2","author":"Medical Research Council","year":"1971","unstructured":"Medical Research Council (1971) Controlled trial of azathioprine and prednosone in chronic renal disease. Report of a Medical Research Council Working Party. Brit Med J 2:239\u2013247","journal-title":"Brit Med J"},{"key":"BF01738153_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.1974.129","volume":"6","author":"J Donadio","year":"1974","unstructured":"Donadio J, Holley K, Anderson C, Taylor W (1974) Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 6:431\u2013439","journal-title":"Kidney Int"},{"key":"BF01738153_CR23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ki.1975.111","volume":"8","author":"G Lagrue","year":"1975","unstructured":"Lagrue G, Bernard D, Bariety J, Druet P, Guenel J (1975) Controlled trial of chlorambucil and azathioprine in idiopathic chronic glomerulonephritis (Abstract), Kidney Int 8:274","journal-title":"Kidney Int"},{"key":"BF01738153_CR24","unstructured":"Tiller D, Clarkson A, Mathew T, Thompson N, Row G, Lauer C, Hobbs J, Seymour A (1981) A prospektive randomized trial in the use of cyclophosphamide, dipyridamole and warfarin in membranous and mesangiocapillary glomerulonephritis. Proc 8th Int Congr Nephrol Athens, 345\u2013351"},{"key":"BF01738153_CR25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","volume":"310","author":"C Ponticelli","year":"1984","unstructured":"Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L et al. (1984) Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. New Engl J Med 310:946\u2013950","journal-title":"New Engl J Med"},{"key":"BF01738153_CR26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/BF01715839","volume":"60","author":"A Vogt","year":"1982","unstructured":"Vogt A, Batsford S (1982) Eine neue Vorstellung zur Pathogenese der Immunkomlexnephritis. Klin Wochenschr 60:1095\u20131101","journal-title":"Klin Wochenschr"},{"key":"BF01738153_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000166665","volume":"2","author":"K Andrassy","year":"1982","unstructured":"Andrassy K, Ritz E, Mauerhoff T, Bommer J (1982) What is the evidence for activated coagulation in glomerulonephritis? Am J Nephrol 2:293\u2013300","journal-title":"Am J Nephrol"},{"key":"BF01738153_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.4.5728.145","volume":"1","author":"P Kincaid-Smith","year":"1970","unstructured":"Kincaid-Smith P, Lacer M, Fairley K, Mathews D (1970) Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. Med J Austral 1:145\u2013151","journal-title":"Med J Austral"},{"key":"BF01738153_CR29","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198405313102203","volume":"310","author":"J Donadio","year":"1984","unstructured":"Donadio J, Anderson C, Mitchell J, Holley K, Ilstrup D, Fuster V, Chesebro J (1984) Membranoproliferative Glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. New Engl J Med 310:1421\u20131426","journal-title":"New Engl J Med"},{"key":"BF01738153_CR30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/0002-9343(83)90864-1","volume":"75","author":"S Zimmermann","year":"1983","unstructured":"Zimmermann S, Moorthy A, Dreher W, Friedman A, Varanasi A (1983) Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 75:920\u2013927","journal-title":"Am J Med"},{"key":"BF01738153_CR31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1985.28","volume":"27","author":"D Cattran","year":"1985","unstructured":"Cattran D, Cardella C, Roscoe J, Charron R, Rance P, Ritchie S, Vorey P (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27:436\u2013441","journal-title":"Kidney Int"},{"key":"BF01738153_CR32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/BF01476873","volume":"58","author":"K Andrassy","year":"1980","unstructured":"Andrassy K, Ritz E, Bommer J (1980) Hypercoagulability in the nephrotic syndrome. Klin Wochenschr 58:1029\u20131036","journal-title":"Klin Wochenschr"},{"key":"BF01738153_CR33","unstructured":"Volhard F (1923) Der arterielle Hochdruck. Verh Dtsch Ges Inn Med 134\u2013175"},{"key":"BF01738153_CR34","first-page":"F85","volume":"241","author":"Th Hostetter","year":"1981","unstructured":"Hostetter Th, Olson J, Rennke H, Venkatachalam M, Brenner B (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85-F93","journal-title":"Am J Physiol"},{"key":"BF01738153_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ki.1982.163","volume":"22","author":"J Neugarten","year":"1982","unstructured":"Neugarten J, Feiner H, Schacht M, Gallo G, Baldwin D (1982) Aggravation of experimental glomerulonephritis by superimposed clip hypertension. Kidney Int 22:257\u2013263","journal-title":"Kidney Int"},{"key":"BF01738153_CR36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","volume":"285","author":"C Mogensen","year":"1982","unstructured":"Mogensen C (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Brit Med J 285:685\u2013688","journal-title":"Brit Med J"},{"key":"BF01738153_CR37","first-page":"177","volume-title":"Prevention and Treatment of Diabetic Nephropathy","author":"C Hasslacher","year":"1983","unstructured":"Hasslacher C, Rambausek M, Ritz E (1983) Genesis and management of hypertension in diabetic nephropathy. In: Keen H, Legrain M (eds) Prevention and Treatment of Diabetic Nephropathy. MTP Press, Boston, pp 177\u2013189"},{"key":"BF01738153_CR38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"B Brenner","year":"1982","unstructured":"Brenner B, Meyer T, Hostetter T (1982) Dietary protein intake and the progressive nature of kidney disease. New Engl J Med 307:652\u2013659","journal-title":"New Engl J Med"},{"key":"BF01738153_CR39","first-page":"567","volume":"21","author":"J Rosman","year":"1984","unstructured":"Rosman J, ter Wee P, Piers-Becht G, Sluiter W, van der Woude F, Meijer S, Donker A (1984) Early protein restriction in chronic renal failure. Proc EDTA 21:567\u2013572","journal-title":"Proc EDTA"},{"key":"BF01738153_CR40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(84)90818-3","volume":"II","author":"J Rosman","year":"1984","unstructured":"Rosman J, ter Wee P, Meijer S, Piers-Brecht T, Sluiter W, Donker A (1984) Prospective randomised trial of erarly dietary protein restriction in chronic renal failure. Lancet II:1291\u20131295","journal-title":"Lancet"},{"key":"BF01738153_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1985.46","volume":"27","author":"L Oldrizzi","year":"1985","unstructured":"Oldrizzi L, Rugiu C., Vlavo E, Lupo A et al. (1985) Progression of renal failure in patients with renal disease of diverse etiology on protein restricted diet. Kidney Int 27:553\u2013557","journal-title":"Kidney Int"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01738153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:00:52Z","timestamp":1586282452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01738153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":41,"journal-issue":{"issue":"18","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF01738153"],"URL":"https:\/\/doi.org\/10.1007\/bf01738153","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}